Traumatic brain injury biomarkers market to reach $3.68 billion by 2030 at 21.6% CAGR, driven by rising road traffic accidents and growing adoption of personalized medicine.
Read More
Trastuzumab biosimilars market to reach $24.48 billion by 2030 at 28.9% CAGR, driven by rising prevalence of breast and gastric cancer increasing demand for affordable biologics.
Read More
Transfection technologies market to reach $1.99 billion by 2030 at 8.7% CAGR, driven by rising adoption of gene therapy and growing need for efficient gene delivery tools.
Read More
Transdermal skin patches market to reach $9.57 billion by 2030 at 4.5% CAGR, driven by increasing prevalence of cardiovascular diseases boosting demand for non invasive therapies.
Read More
Transdermal drug delivery systems market to reach $57.94 billion by 2030 at 7.7% CAGR, driven by rising prevalence of chronic diseases requiring long term and controlled drug administration.
Read More
Tramadol drug market to reach $6.76 billion by 2030 at 7.4% CAGR, driven by rising prevalence of orthopedic disorders and increasing healthcare expenditure.
Read More
Toxoplasmosis treatment drugs market to reach $4.66 billion by 2030 at 6.1% CAGR, driven by rising prevalence of toxoplasmosis infections.
Read More
Toxicology drug screening market to reach $33.48 billion by 2030 at 9.2% CAGR, driven by rising prevalence of drug abuse worldwide.
Read More
Topical wound agents market to reach $2.75 billion by 2030 at 7.5% CAGR, driven by rise in road accidents leading to traumatic injuries.
Read More
Topical drugs cdmo market to reach $121.22 billion by 2030 at 14.3% CAGR, driven by increasing prevalence of skin diseases requiring topical therapies.
Read More